Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dupilumab on ASS Intolerance and Its Mechanisms in Patients With Aspirin-exacerbated Respiratory Disease (AERD)

NCT04442256 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT04442256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04442256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dupilumab on ASS Intolerance and Its Mechanisms in Patients With Aspirin-exacerbated Respiratory Disease (AERD)
Lead sponsor
Medical University of Vienna
Phase
Phase 4
Overall status
Unknown status
Start date
June 1, 2020
Completion date
December 31, 2022
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aerd - aspirin exacerbated respiratory disease